Related Experiment Videos
Angiopathic parkinsonism: does it exist?
C Alvisi1, A Borromei, M Cerisoli
1Istituto di Clinica Neurologica, Università degli studi di Bologna.
Abstract:
The Authors report on 150 cases of patients suffering from Parkinson's disease. The patients represent 8.3% of total parkinsonian patients and are selected on the basis of clinical and laboratory criteria that allow the diagnosis of "angiopathic parkinsonism" as an autonomous entity. Cerebral blood flow alterations in Parkinson's disease and associated dementing symptoms are also discussed. In conclusion, the Authors emphasize the usefulness of recognizing the "angiopathic parkinsonism" in view of therapeutical implications.
Insights
This study identifies "angiopathic parkinsonism" in 150 patients, highlighting its distinct nature. Recognizing this condition is crucial for effective Parkinson's disease treatment strategies.
Area of Science:
- Neurology
- Cerebrovascular Diseases
- Neurodegenerative Disorders
Background:
- Parkinson's disease (PD) is a complex neurodegenerative disorder.
- Cerebral blood flow alterations are observed in PD patients, potentially linked to cognitive decline.
- Differentiating subtypes of parkinsonism is essential for targeted therapies.
Purpose of the Study:
- To report on 150 cases diagnosed with "angiopathic parkinsonism" as a distinct clinical entity.
- To investigate cerebral blood flow alterations in Parkinson's disease patients.
- To discuss the diagnostic criteria and therapeutic implications of angiopathic parkinsonism.
Main Methods:
- Clinical and laboratory assessments were used to diagnose 150 patients with angiopathic parkinsonism.
- Analysis of cerebral blood flow in Parkinson's disease patients.
- Review of associated dementing symptoms.
Main Results:
- Angiopathic parkinsonism was identified in 150 patients, representing 8.3% of the total parkinsonian cohort.
- The study established diagnostic criteria for "angiopathic parkinsonism" as an autonomous entity.
- Cerebral blood flow alterations and dementing symptoms were discussed in relation to the condition.
Conclusions:
- "Angiopathic parkinsonism" can be recognized as a distinct clinical entity.
- Identifying angiopathic parkinsonism has significant therapeutic implications for patient management.
- Further research into cerebral blood flow is warranted for understanding PD subtypes.